Cardiac sarcomeric function, small G-protein signaling, and heart failure

Area of Science:

• Cardiovascular Biology
• Molecular Signaling
• Cellular Mechanics

Background:

• Cardiac hypertrophy and heart failure result from complex molecular signaling.
• Both external (hypertension) and internal (genetic defects) stresses trigger these pathways.
• G-protein coupled receptors initiate signaling cascades leading to altered gene expression and protein phosphorylation.

Purpose of the Study:

• To review the functional effects of small G-protein (Ras and Rho) signaling pathways in the cytoplasm.
• To understand how these pathways influence myofilament protein phosphorylation and cardiac function.
• To highlight the importance of these pathways in cardiac and vascular biology for therapeutic development.

Main Methods:

• Literature review focusing on small G-protein signaling.
• Analysis of molecular mechanisms linking G-proteins to myofilament protein phosphorylation.
• Examination of the role of kinases and phosphatases in these signaling cascades.

Main Results:

• Small G-proteins Ras and Rho mediate signaling downstream of membrane receptors.
• Phosphorylation of myofilament proteins by these pathways alters cardiac mechano-energetics.
• These alterations in protein function contribute to altered contractility and heart failure.

Conclusions:

• Small G-protein signaling pathways are key regulators of cardiac hypertrophy and decompensation.
• Understanding these cytoplasmic pathways is vital for developing targeted therapies.
• Inhibitors of small G-protein effectors, like p38 MAP kinase and Rho-dependent kinase, show therapeutic potential.